Amelanotic/hypopigmented melanoma in a sibship with oculocutaneous albinism. Issue 11 (27th July 2022)

• Record Type: Journal Article
• Authors: Maas, Ellie J.; Wallingford, Courtney K.; McGuire, Jessica J.; Rutjes, Chantal; Smit, Darren J.; Betz‐Stablein, Brigid; Sturm, Richard A.; Soyer, H. Peter; McInerney‐Leo, Aideen M.
• Is Part Of: Journal of dermatology. Volume 49:Issue 11(2022)
• Page Start: 1183
• Page End: 1187
• Publication Date: 2022-07-27
• Subjects: Three‐dimensional imaging -- amelanotic/hypopigmented -- melanoma -- oculocutaneous albinism -- PARP1; Dermatology -- Periodicals; Dermatology -- Japan -- Periodicals; Skin -- Diseases -- Periodicals; 616.5005
• DOI: 10.1111/1346-8138.16528
• Languages: English
• ISSNs: 0385-2407

Abstract

Abstract: Oculocutaneous albinism (OCA) is a rare condition characterized by hypopigmentation. A female proband and her sister, both with primary amelanotic/hypopigmented melanoma, underwent three‐dimensional total‐body photography and dermoscopy. Both sisters had exome sequencing along with their brother, who had OCA but no history of melanoma. Imaging analysis was consistent with OCA in terms of individual typology angle scores, degree of sun damage, and high naevus counts. Exome data filtered for variants in known OCA and melanoma/naevi susceptibility genes ( n = 98) found all siblings were compound heterozygous for TYR mutations (Arg402Ter and Val275Phe), previously reported as causative OCA variants. A rare missense variant in PARP1 (p.Pro377Ser) was solely present in the melanoma‐unaffected brother, which is noteworthy as this was previously reported as potentially protective in a familial melanoma pedigree positive for CDKN2A mutations. Evaluation and confirmation of functional impact in larger cohorts could personalize melanoma screening in OCA.